Sangamo Therapeutics, Inc. (SGMOQ)
0.1649
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Sangamo Therapeutics Total Long Term Debt (Quarterly) : 19.33M for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 19.33M |
| December 31, 2025 | 25.09M |
| September 30, 2025 | 25.42M |
| June 30, 2025 | 23.46M |
| March 31, 2025 | 24.88M |
| December 31, 2024 | 26.25M |
| September 30, 2024 | 27.73M |
| June 30, 2024 | 29.10M |
| March 31, 2024 | 30.82M |
| December 31, 2023 | 33.52M |
| September 30, 2023 | 34.98M |
| June 30, 2023 | 36.37M |
| March 31, 2023 | 37.70M |
| December 31, 2022 | 38.99M |
| September 30, 2022 | 39.70M |
| June 30, 2022 | 41.53M |
| March 31, 2022 | 42.82M |
| December 31, 2021 | 44.06M |
| September 30, 2021 | 36.12M |
| June 30, 2021 | 37.33M |
| March 31, 2021 | 38.46M |
| December 31, 2020 | 38.40M |
| September 30, 2020 | 38.26M |
| June 30, 2020 | 39.23M |
| March 31, 2020 | 40.20M |
| Date | Value |
|---|---|
| December 31, 2019 | 41.19M |
| September 30, 2019 | 40.61M |
| June 30, 2019 | 41.55M |
| March 31, 2019 | 13.30M |
| December 31, 2018 | 27.69M |
| September 30, 2018 | 26.93M |
| June 30, 2018 | 26.18M |
| March 31, 2018 | 25.45M |
| December 31, 2017 | 24.74M |
| September 30, 2017 | 3.87M |
| June 30, 2017 | 3.887M |
| March 31, 2017 | 3.928M |
| December 31, 2016 | 3.945M |
| September 30, 2016 | 2.256M |
| June 30, 2016 | 0.247M |
| March 31, 2016 | 0.213M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Anixa Biosciences, Inc. | 0.14M |
| Vicapsys Life Sciences, Inc. | 0.00 |